![David Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 511 $ al 30/06/2026
David Ian Wilson is the founder of WG Partners LLP, established in 2011, where the title held is Chairman.
Current jobs include Independent Non-Executive Director at Bionomics Ltd. since 2016, Director at CS Pharmaceuticals Ltd. since 2021, Non Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd., Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, Senior Board Advisor at Sapia Partners LLP, and Member-Governors Board at Harris Academy Bromley since 2015.
Former jobs include Chief Executive Officer at Piper Sandler Ltd., Deputy Chief Executive Officer at Matrix Corporate Capital LLP in 2011, Independent Non-Executive Director at Optos Plc from 2012 to 2013, Non-Executive Director at Oncoinvent ASA from 2013 to 2016, Head-Small Companies Corporate Finance at Deutsche Bank AG from 1998 to 1999, Joint Head-UK Investment Banking Group at ING Barings Group LLC from 1999 to 2001, and Head-Small Companies Corporate Broking at UBS AG (London Branch).
Education includes undergraduate degree from the University of Cambridge.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0 % | 20/01/2026 | 117 ( 0 % ) | 511 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
WG Partners LLP
 WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Fundador | 01/10/2011 |
Harris Academy Bromley | Director/Miembro de la Junta | - |
Sapia Partners LLP
 Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Director/Miembro de la Junta | 16/06/2016 |
CS Pharmaceuticals Ltd. | Director/Miembro de la Junta | 01/07/2021 |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOINVENT ASA | Director/Miembro de la Junta | 01/01/2016 |
Matrix Corporate Capital LLP
 Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/10/2011 |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Director Ejecutivo | 01/01/2011 |
| ░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Deutsche Bank AG /UK/
 Deutsche Bank AG /UK/ Investment Banks/BrokersFinance Deutsche Bank UK is an active manager which constructs tailored investment strategies in line with their clients' risk/reward profile for a variety of strategies including aggressive growth, growth, income or security. They construct portfolios comprised of asset classes such as bonds, equities, alternative investments and foreign exchange. The firm bases their investment decisions on the group's worldwide network of experts, in addition to their regional and local expertise. | Finance |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
ING Barings Group LLC
 ING Barings Group LLC Investment Banks/BrokersFinance Provides investment banking and financial services | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optos Plc
 Optos Plc Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets retinal imaging devices | Health Technology |
UBS AG (London Branch)
 UBS AG (London Branch) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Matrix Corporate Capital LLP
Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Sapia Partners LLP
Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
WG Partners LLP
WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harris Academy Bromley | |
CS Pharmaceuticals Ltd. | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
